Skip to main content
Top
Published in: Cancer Causes & Control 6/2012

01-06-2012 | Original paper

Breast-feeding and risk of epithelial ovarian cancer

Authors: S. J. Jordan, K. L. Cushing-Haugen, K. G. Wicklund, J. A. Doherty, M. A. Rossing

Published in: Cancer Causes & Control | Issue 6/2012

Login to get access

Abstract

Purpose

Evidence suggests that breast-feeding may decrease the risk of epithelial ovarian cancer but it is not clear whether there is a relationship with duration of breast-feeding, patterns of breast-feeding, or particular histological subtypes of ovarian cancer. We sought to investigate these issues in detail.

Methods

Data from participants in a population-based study of ovarian cancer in western Washington State, USA (2002–2007) who had had at least one birth (881 cases and 1,345 controls) were used to assess relations between patterns of breast-feeding and ovarian cancer. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI).

Results

Women who ever breast-fed had a 22 % reduction in risk of ovarian cancer compared with those who never breast-fed (OR = 0.78, 95% CI 0.64–0.96) and risk reduction appeared greater with longer durations of feeding per child breast-fed (OR = 0.56, 95% CI 0.32–0.98 for 18 months average duration breast-feeding versus none). Introduction of supplementary feeds did not substantially alter these effects. The overall risk reduction appeared greatest for the endometrioid and clear cell subtypes (OR per month of average breast-feeding per child breast-fed = 0.944, 95% CI 0.903–0.987).

Conclusions

Among women who have had the opportunity to breast-feed, ever breast-feeding and increasing durations of episodes of breast-feeding for each breast-fed child are associated with a decrease in the risk of ovarian cancer independent of numbers of births, which may be strongest for the endometrioid subtype.
Literature
1.
2.
go back to reference Risch H (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90(23):1774–1786PubMedCrossRef Risch H (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90(23):1774–1786PubMedCrossRef
3.
4.
go back to reference Ip S, Chung M, Raman G, Trikalinos TA, Lau J (2009) A summary of the Agency for Healthcare Research and Quality’s evidence report on breastfeeding in developed countries. Breastfeed Med 4(Suppl 1):S17–S30. doi:10.1089/bfm.2009.0050 PubMed Ip S, Chung M, Raman G, Trikalinos TA, Lau J (2009) A summary of the Agency for Healthcare Research and Quality’s evidence report on breastfeeding in developed countries. Breastfeed Med 4(Suppl 1):S17–S30. doi:10.​1089/​bfm.​2009.​0050 PubMed
5.
go back to reference Mills PK, Riordan DG, Cress RD (2004) Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol 95(1):215–225PubMedCrossRef Mills PK, Riordan DG, Cress RD (2004) Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol 95(1):215–225PubMedCrossRef
6.
go back to reference Huusom LD, Frederiksen K, Hogdall EV, Glud E, Christensen L, Hogdall CK, Blaakaer J, Kjaer SK (2006) Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Cancer Causes Control 17(6):821–829. doi:10.1007/s10552-006-0022-x PubMedCrossRef Huusom LD, Frederiksen K, Hogdall EV, Glud E, Christensen L, Hogdall CK, Blaakaer J, Kjaer SK (2006) Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Cancer Causes Control 17(6):821–829. doi:10.​1007/​s10552-006-0022-x PubMedCrossRef
7.
go back to reference Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE (2007) Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control 18(5):517–523PubMedCrossRef Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE (2007) Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control 18(5):517–523PubMedCrossRef
10.
go back to reference Zhang M, Xie X, Lee AH, Binns CW (2004) Prolonged lactation reduces ovarian cancer risk in Chinese women. Eur J Cancer Prev 13(6):499–502PubMedCrossRef Zhang M, Xie X, Lee AH, Binns CW (2004) Prolonged lactation reduces ovarian cancer risk in Chinese women. Eur J Cancer Prev 13(6):499–502PubMedCrossRef
11.
go back to reference Chiaffarino F, Pelucchi C, Negri E, Parazzini F, Franceschi S, Talamini R, Montella M, Ramazzotti V, La Vecchia C (2005) Breastfeeding and the risk of epithelial ovarian cancer in an Italian population. Gynecol Oncol 98(2):304–308PubMedCrossRef Chiaffarino F, Pelucchi C, Negri E, Parazzini F, Franceschi S, Talamini R, Montella M, Ramazzotti V, La Vecchia C (2005) Breastfeeding and the risk of epithelial ovarian cancer in an Italian population. Gynecol Oncol 98(2):304–308PubMedCrossRef
13.
go back to reference Frtiz AG (2000) International classification of diseases for oncology ICD-O, 3rd edn. WHO, Geneva Frtiz AG (2000) International classification of diseases for oncology ICD-O, 3rd edn. WHO, Geneva
14.
go back to reference World Cancer Resarch Fund/American Institue for Cancer Research. Food, nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective (2007). AICR, Washington DC World Cancer Resarch Fund/American Institue for Cancer Research. Food, nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective (2007). AICR, Washington DC
15.
go back to reference Tung KH, Wilkens LR, Wu AH, McDuffie K, Nomura AM, Kolonel LN, Terada KY, Goodman MT (2005) Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 161(4):321–329PubMedCrossRef Tung KH, Wilkens LR, Wu AH, McDuffie K, Nomura AM, Kolonel LN, Terada KY, Goodman MT (2005) Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 161(4):321–329PubMedCrossRef
16.
go back to reference Riman T, Dickman P, Nilsson S, Correia N, Nordlinder H, Magnusson C, Persson I (2002) Risk factors for Invasive Epithelial Ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 156(4):363–373PubMedCrossRef Riman T, Dickman P, Nilsson S, Correia N, Nordlinder H, Magnusson C, Persson I (2002) Risk factors for Invasive Epithelial Ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 156(4):363–373PubMedCrossRef
17.
go back to reference Modugno F, Ness RB, Wheeler J (2001) Reproductive risk factors for epithelial ovarian cancer according to histological type and invasiveness. Ann Epidemiol 11:568–574PubMedCrossRef Modugno F, Ness RB, Wheeler J (2001) Reproductive risk factors for epithelial ovarian cancer according to histological type and invasiveness. Ann Epidemiol 11:568–574PubMedCrossRef
20.
go back to reference Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83(9):783–795PubMed Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83(9):783–795PubMed
22.
go back to reference Heinig MJ, Nommsen-Rivers LA, Peerson JM, Dewey KG (1994) Factors related to duration of postpartum amenorrhoea among USA women with prolonged lactation. J Biosoc Sci 26(4):517–527PubMedCrossRef Heinig MJ, Nommsen-Rivers LA, Peerson JM, Dewey KG (1994) Factors related to duration of postpartum amenorrhoea among USA women with prolonged lactation. J Biosoc Sci 26(4):517–527PubMedCrossRef
Metadata
Title
Breast-feeding and risk of epithelial ovarian cancer
Authors
S. J. Jordan
K. L. Cushing-Haugen
K. G. Wicklund
J. A. Doherty
M. A. Rossing
Publication date
01-06-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 6/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9963-4

Other articles of this Issue 6/2012

Cancer Causes & Control 6/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine